A strong team with experience and know-how


Patrick Brenske – Vorstand
Patrick Brenske

Patrick Brenske

After completing his university studies with a Master of Finance & Banking (M.Sc.) degree from the Frankfurt School of Finance & Management, Herr Brenske was a management member at HAEMATO AG from 2007 until 2012. Since 2009 he is a member of the board of MPH Health Care AG. In June 2015, Mr. Brenske became CEO of M1 Kliniken AG.

Dr. Walter von Horstig - Vorstand
Dr. Walter von Horstig

Dr. Walter von Horstig

Dr. von Horstig studied business administration at the University of Mannheim and St. Gall, where he also completed his PhD thesis. From 1993 to 1998 he worked as a management consultant for Bain & Company and the ABB Group. From 1999 to 2004, Dr. von Horstig was founder, managing director and board member of several start-up companies in the service and biotech sector, before joining the Underberg Group as Commercial Director. From 2009 to the beginning of 2017, Dr. von Horstig was the Managing Director of a DRK blood donation service and was responsible for a fundamental economic restructuring of the company. In April 2017, he joined the M1 Med Beauty Berlin GmbH as Managing Director before being appointed to the Management Board of M1 Kliniken AG in October 2017.


Dr. Albert Wahl
Uwe Zimdars
Prof. Dr. Dr. Sabine Meck

Latest news

| Corporate News

  • Group revenues decrease by only 12 % to 29.1 million Euro despite loss of about 1/3 of treatment days
  • Consolidated net income of 2.0 million Euro
  • High utilization of the specialized centers after resumption of patient treatments

| Corporate News

Yesterday, M1 Kliniken AG successfully held its Annual General Meeting 2020. In his presentation, the Management Board gave an outline of the company's prosperous development in the 2019 financial year, which was accompanied by a significant …

| Corporate News

M1 Kliniken AG acquires about 48 % of the share capital of HAEMATO AG from MPH Health Care AG. Transfer of the HAEMATO shares within the framework of a capital increase through contribution in kind Focus of both companies on their respective core …

| Ad-hoc news

M1 Kliniken AG acquires ca. 48% of the shares of HAEMATO AG - transfer of the shares in a capital increase against contribution in kind of M1 Kliniken AG